Trade GDTC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
CytoMed Therapeutics Limited (GDTC) is trading at US$0.90, down 4.95% today as of Aug 28, 10:05 EDT. The company has a market capitalisation of US$12.19M. Over the past 52 weeks, GDTC has traded between US$0.68 and US$3.68. On Syfe you can trade GDTC with $0 commission and add it to your watchlist.
| Previous close | US$0.95 |
|---|---|
| Market cap | US$12.19M |
| 52-week range | US$0.68 – US$3.68 |
| Volume | 18.94K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
Year: 2023
CytoMed Therapeutics Limited (GDTC) stock is trading at US$0.90, -4.95% from the previous close of US$0.95.
The market cap for CytoMed Therapeutics Limited (GDTC) stock is approximately US$12.19M.
The 52-week high for CytoMed Therapeutics Limited (GDTC) stock is US$3.68.
The 52-week low for CytoMed Therapeutics Limited (GDTC) stock is US$0.68.
CytoMed Therapeutics Limited (GDTC) does not currently pay a dividend.
Stay on top of GDTC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
